Synaffix Named 'Biotech Company of the Year' at the LSX Euro

AMSTERDAM, Nov. 16, 2022 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug

Related Keywords

United Kingdom , London , City Of , Amsterdam , Noord Holland , Netherlands , Innovent Biologics , Kostenloser Wertpapierhandel , Biotech Company Of The Year , Platform Technology , Biotech Company , European Lifestars Awards Ceremony , Old Billingsgate , European Lifestars Awards , Mersana Therapeutics , Kyowa Kirin , Emergence Therapeutics , Chief Executive Officer , Shanghai Miracogen , Biogeneration Ventures , Synaffix , Amed , Biotech , Company , Ear , European , Ifestars , Awards ,